Get the Stockscreener App
87.23
0.00%
-0.13
Ishares U S Pharmaceuticals Etf stock is traded at $87.23, with a volume of 1,643.
It is down -0.00% in the last 24 hours and up +0.29% over the past month.
See More
Previous Close:
$87.36
Open:
$87.28
24h Volume:
1,643
Relative Volume:
0.02
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.00%
1M Performance:
+0.29%
6M Performance:
+17.77%
1Y Performance:
+41.02%
1-Day Range:
$87.28
$87.44
1-Week Range:
$86.58
$88.77
52-Week Range:
$62.02
$92.30
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Name
Ishares U S Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare IHE vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IHE
Ishares U S Pharmaceuticals Etf
|
87.44 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
345.38 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
699.95 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
703.20 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
279.96 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
636.67 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf Stock (IHE) Latest News
What Johnson & Johnson Earnings Signal for Healthcare ETFs - ETF Trends
iShares U.S. Pharmaceuticals ETF (IHE) - Minichart
Anfield US Equity Sector Rotation ETF's iShares U.S. Pharmaceuticals ETF(IHE) Holding History - GuruFocus
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - sharewise.com
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
Trump Administration Prepares Up To 100% Pharma Tariffs On Drugs From Companies That Have Not Struck A Deal Yet: Report - Stocktwits
Stock List: Research Stocks from Around the World - GuruFocus
Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything - The Motley Fool
Healthcare ETFs in Spotlight Amid Eli Lily's $2.8B AI Drug Move - The Globe and Mail
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - sharewise.com
With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize - AOL.com
iShares US Pharmaceuticals ETF declares quarterly distribution of $0.2845 - MSN
Is the Invesco Pharmaceuticals ETF (PJP) Currently a Top ETF Choice? - Bitget
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - Yahoo News Malaysia
Should you consider putting your money into the iShares U.S. Pharmaceuticals ETF (IHE)? - Bitget
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance
PPH, IHE, PJP: U.S. Pharmaceutical ETFs Offer Investors Innovation and Growth - TipRanks
IHE: U.S. Pharmaceuticals ETF With Excellent GARP Features (NYSEARCA:IHE) - Seeking Alpha
Eli Lilly Dominance: The Impact of a Single Stock on Pharma ETF Performance - Intellectia AI
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)? - Yahoo Finance
ETFs with Pfizer Inc. ( PFE ) Exposure - ETF Database
XPH’s 29% Run Looks Tempting, But The 5y Chart Is A Warning - 24/7 Wall St.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)? - Yahoo Finance
Cibc World Market Inc. Sells 18,704 Shares of iShares U.S. Healthcare ETF $IYH - Defense World
5 biggest pharmaceutical ETFs for investors in 2026 - MSN
7 Best Biotech ETFs to Buy Now | Investing - US News Money
iShares U.S. Technology ETF $IYW Stake Lifted by Principal Financial Group Inc. - Defense World
XLP Delivers Pure-Play Staples While IYK Adds Healthcare. Which Strategy Wins? - AOL.com
Best Biotech ETFs to Buy in 2026 - The Motley Fool
U.S. Pharmaceutical Giants Drive ETF Performance with Strong Results - AD HOC NEWS
Analyst Target Prices Indicate Potential for Pharmaceuticals ETF - Intellectia AI
UnitedHealth Flags Margin Stress, Pushing Investors Toward Broader Healthcare ETFs - Benzinga
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - sharewise.com
3 Healthcare ETFs to Buy as Flat Medicare Rate Proposal Hits Insurers - TradingView
ETFs to Buy Post JNJ's Q4 Earnings Surprise & Bullish Cash Flow View - The Globe and Mail
Economist Warns Trump's Full Drug Tariff Will Burden Americans, Not Foreign Companies - intellectia.ai
5 Biggest Pharmaceutical ETFs for Investors in 2026 - Nasdaq
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan - The Globe and Mail
Looking for Exposure to Johnson & Johnson Stock (JNJ) ahead of Q4 Earnings? Here’s How to Buy Without the Risk - TipRanks
Should you invest in the iShares US Pharmaceuticals ETF (IHE)? - MSN
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' - Benzinga
Top 3 Medical Device ETFs for Investors in 2026 - Investing News Network
Should You Invest in the iShares U.S. Utilities ETF (IDU)? - Yahoo Finance
How to Buy Eli Lilly Stock (LLY) - The Motley Fool
How to Buy Johnson & Johnson Stock (JNJ) - The Motley Fool
4 Top-Ranked ETF Areas That Beat the Market in 2025 - The Globe and Mail
Ishares U S Pharmaceuticals Etf Stock (IHE) Financials Data
There is no financial data for Ishares U S Pharmaceuticals Etf (IHE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.24%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):